Activities of Bolesław G. PIECHA related to 2017/2254(INI)
Plenary speeches (1)
A European One Health Action Plan against Antimicrobial Resistance (debate) PL
Shadow reports (1)
REPORT on a European One Health Action Plan against Antimicrobial Resistance (AMR) PDF (545 KB) DOC (117 KB)
Amendments (15)
Amendment 40 #
Motion for a resolution
Recital B a (new)
Recital B a (new)
Ba. whereas the continued spreading of highly resistant bacteria could make it impossible in the future to provide for good healthcare with regard to invasive operations or well established treatments for some groups of patients requiring radiotherapy, chemotherapy or transplants;
Amendment 81 #
Motion for a resolution
Paragraph 1
Paragraph 1
1. Believes that in order to take sufficient steps to tackle AMR, the One Health principle must play a central role, reflecting the fact that the health of people and animals are interconnected and that diseases are transmitted from people to animals and vice versa; stresses, therefore, that diseases have to be tackled in both people and animals, while also taking into consideration the environment, which can be another source of resistant microorganisms; underlines the important role of the Commission in coordinating and monitoring national action plans carried out by Member States;
Amendment 151 #
Motion for a resolution
Paragraph 4 a (new)
Paragraph 4 a (new)
4a. Highlights that better sharing of local, regional and national information and data on emerging issues in human and animal health together with the use of early warning systems can assist Member States in adopting appropriate containment measures to limit the spread of resistant organisms;
Amendment 153 #
Motion for a resolution
Paragraph 5
Paragraph 5
Amendment 191 #
Motion for a resolution
Paragraph 8
Paragraph 8
8. Urges the Commission and Member States to create harmonisedCalls on Member States to ensure the highest quality standards in EU-wide curricula and proper stewardship for health professionals in relation to prescribing, dosage, use and disposal of antimicrobials; urges that continuing professional development programmes for clinicians include the latest best practices in effective antibiotic stewardship;
Amendment 210 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Is aware that the cost of rapid diagnostic tools (RDT) may exceed the price of antibiotics; calls on the Commission and Member States to propose incentives for the industry to develop effective and efficient testing methods, and calls on health insurance carrs research is needed to develop new technologiers to cover the extra cost arising from the use of RDT, given the long-term benefits of preventing the unnecessary use of antimicrobialdifferentiate between bacterial and viral infections, identify the organisms causing disease and reduce reliance on traditional antibiotics;
Amendment 227 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. Calls on the Commission and the Member States to restrict or stop the online sale of antibiotics by those doctors or veterinarians who prescribe themmicrobials and to ensure that patients and animals only receive the specific quantity of antibiotics as appropriately and responsibly prescribed by doctors and veterinarians;
Amendment 241 #
Motion for a resolution
Paragraph 11 a (new)
Paragraph 11 a (new)
11 a. Calls on Member States to ensure greater levels of adherence to and compliance with antibiotic treatments as prescribed by medical professionals and greater understanding amongst patients of the importance of responsible use of antibiotics and the risks of increasing antimicrobial resistance;
Amendment 248 #
Motion for a resolution
Paragraph 11 b (new)
Paragraph 11 b (new)
11 b. Notes that some Member States have legally defined professionally qualified animal medicines advisors authorised to prescribe certain veterinary medicines by the relevant authorities; underlines that national action plans on antimicrobial resistance should not prohibit these persons, when necessary, from prescribing and supplying certain veterinary medicines, given the vital role these persons can play in isolated rural communities;
Amendment 296 #
Motion for a resolution
Paragraph 14 a (new)
Paragraph 14 a (new)
14 a. Underlines that good farm management, bio-security and animal husbandry systems underpin the health and welfare of food-producing animals and when applied appropriately, minimise susceptibility to bacterial disease and minimise the need for antibiotic use in animals;
Amendment 330 #
Motion for a resolution
Paragraph 16 a (new)
Paragraph 16 a (new)
16 a. Notes that the research and development of novel approaches to the treatment and prevention of infections is equally important and can include using substances to strengthen the immune response to bacterial infection, such as pre and probiotics;
Amendment 356 #
Motion for a resolution
Paragraph 19 a (new)
Paragraph 19 a (new)
19 a. Recalls the value of developing coalitions between academia and biopharmaceutical companies in terms of developing new antibiotics, rapid diagnostics and novel therapies;
Amendment 378 #
Motion for a resolution
Paragraph 22
Paragraph 22
22. Notes the hesitant approach of the industry to develop ‘last-line’ antibiotics against bacteria that are resistant to all other antibiotics owing to expected low profitability; calls for incentives freminds industry of its corporate and social responsibility to contribute to work this research and definition of the regulatory pathwayo tackle AMR by finding ways to extend the life of antibiotics, making the supply of effective antibiotics sustainable, and calls for incentives for this research;
Amendment 397 #
Motion for a resolution
Paragraph 24
Paragraph 24
24. Recalls that owing to the complexity of the problem, its cross-border dimension, the severe consequences for human and animal health and the high economic burden, AMR requires urgent and coordinated global and intersectoral action; emphasises in this regard the importance of building international partnerships and coalitions to influence change at national, European and international level on the more efficient discovery and development of medicines, vaccines and diagnostics;
Amendment 448 #
Motion for a resolution
Paragraph 29
Paragraph 29
29. Calls on the Commission to work towards continuedand Member States to work to demonstrate leadership in terms of high-level political attention and commitment to AMR action, including in UN forums, the G7 and the G20;